Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Toplak Hermann |

** = Publikationen gelistet in SCI/SSCI/Pubmed

2024

Originalarbeit (Zeitschrift)

** Deanfield, J; Verma, S; Scirica, BM; Kahn, SE; Emerson, SS; Ryan, D; Lingvay, I; Colhoun, HM; Plutzky, J; Kosiborod, MN; Hovingh, GK; Hardt-Lindberg, S; Frenkel, O; Weeke, PE; Rasmussen, S; Goudev, A; Lang, CC; Urina-Triana, M; Pietilä, M; Lincoff, AM, , SELECT, Trial, Investigators Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial.
Lancet. 2024; 404(10454): 773-786. Doi: 10.1016/S0140-6736(24)01498-3
Web of Science PubMed FullText FullText_MUG

 

** Ebenbichler, C; Drexel, H; Hanusch, U; Toplak, H; Dhalwani, NN; Bridges, I; Hoelzl, R; Hemetsberger, M; Ray, KK Evolocumab effectiveness in the real-world setting: Austrian data from the pan-European observational HEYMANS study.
Wien Klin Wochenschr. 2024; 136(3-4): 77-86. Doi: 10.1007/s00508-023-02245-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** European Atherosclerosis Society Familial Hypercholesterolaemia Studies Collaboration Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study.
Lancet. 2024; 403(10421): 55-66. Doi: 10.1016/S0140-6736(23)01842-1
Web of Science PubMed FullText FullText_MUG

 

** Lingvay, I; Deanfield, J; Kahn, SE; Weeke, PE; Toplak, H; Scirica, BM; Rydén, L; Rathor, N; Plutzky, J; Morales, C; Lincoff, AM; Lehrke, M; Jeppesen, OK; Gajos, G; Colhoun, HM; Cariou, B; Ryan, D, , SELECT, Trial, Investigators Semaglutide and Cardiovascular Outcomes by Baseline HbA1c and Change in HbA1c in People With Overweight or Obesity but Without Diabetes in SELECT.
Diabetes Care. 2024; 47(8):1360-1369 Doi: 10.2337/dc24-0764 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ray, KK; Aguiar, C; Arca, M; Connolly, DL; Eriksson, M; Ferrières, J; Laufs, U; Mostaza, JM; Nanchen, D; Bardet, A; Lamparter, M; Chhabra, R; Soronen, J; Rietzschel, E; Strandberg, T; Toplak, H; Visseren, FLJ; Catapano, AL Use of combination therapy is associated with improved LDL-cholesterol management: 1-year follow-up results from the European observational SANTORINI study.
Eur J Prev Cardiol. 2024; Doi: 10.1093/eurjpc/zwae199
Web of Science PubMed FullText FullText_MUG

 

** Scirica, BM; Lincoff, AM; Lingvay, I; Bogdanski, P; Buscemi, S; Colhoun, H; Craciun, AE; Ezhov, M; Hardt-Lindberg, S; Kleist, Jeppesen, O; Matos, ALSA; Node, K; Schiele, F; Toplak, H; van, Beek, A; Weeke, PE; Wiviott, SD; Deanfield, J; Ryan, D The Effect of Semaglutide on Mortality and COVID-19-Related Deaths: An Analysis From the SELECT Trial.
J Am Coll Cardiol. 2024; Doi: 10.1016/j.jacc.2024.08.007
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Innerhofer, R; Ebenbichler, C; Baumgartner-Kaut, M; Esterbauer, H; Fasching, P; Ferch, M; Galli, L; Greber-Platzer, S; Grohs, K; Harreiter, J; Karall, D; Kleemann, L; Klein, D; Krychtiuk, K; Mäser, M; Rega-Kaun, G; Scholl-Bürgi, S; Schwaiger, E; Speidl, W; Stulnig, T; Stögerer-Lanzenberger, M; Sunder-Plassmann, R; Toplak, H; Widhalm, K; Witsch-Baumgartner, M; Winhofer, Y; Dieplinger, J; Binder, C VARIANT-SPECIFIC LDL-CHOLESTEROL PATTERNS AND RISK OF ATHEROSCLEROTIC CARDIOVASCULAR DISEASE IN HETEROZYGOUS FH: INSIGHTS FROM THE AUSTRIAN FH-REGISTRY
ATHEROSCLEROSIS. 2024; 395: -Annual Meeting EAS 2024; May 26-29; Lyon. [Poster]
Web of Science

 

2023

Originalarbeit (Zeitschrift)

** Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Lebherz-Eichinger, D; Fasching, P; Ebenbichler, C; Kautzky, A; Toplak, H [Mental disorders and diabetes mellitus (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 225-236. Doi: 10.1007/s00508-022-02117-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Brix, JM; Andersen, B; Aydinkoc-Tuzcu, K; Beckerhinn, P; Brossard-Eitzinger, A; Cavini, A; Ciardi, C; Clodi, M; Eichner, M; Erlacher, B; Fahrnberger, M; Felsenreich, DM; Francesconi, C; Göbel, B; Hölbing, E; Hoppichler, F; Huber, J; Huber, SL; Itariu, BK; Jandrasitz, B; Kiefer, FW; Köhler, G; Kruschitz, R; Ludvik, B; Malzner, A; Moosbrugger, A; Öfferlbauer-Ernst, A; Parzer, V; Prager, G; Resl, M; Ress, C; Schelkshorn, C; Scherer, T; Sourji, H; Stechemesser, L; Stulnig, T; Toplak, H; Wakolbinger, M; Vonbank, A; Weghuber, D [Overweight and obesity in adults: general principles of treatment and conservative management].
Wien Klin Wochenschr. 2023; 135(Suppl 6): 706-720. Doi: 10.1007/s00508-023-02270-9 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Catapano, AL; Tokgözoğlu, L; Banach, M; Gazzotti, M; Olmastroni, E; Casula, M; Ray, KK, , Lipid, Clinics, Network, Group Evaluation of lipoprotein(a) in the prevention and management of atherosclerotic cardiovascular disease: A survey among the Lipid Clinics Network.
Atherosclerosis. 2023; 370: 5-11. Doi: 10.1016/j.atherosclerosis.2023.02.007
Web of Science PubMed FullText FullText_MUG

 

** Clodi, M; Abrahamian, H; Brath, H; Schernthaner, G; Brix, J; Ludvik, B; Drexel, H; Saely, CH; Fasching, P; Rega-Kaun, G; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Kautzky-Willer, A; Harreiter, J; Luger, A; Resl, M; Riedl, M; Winhofer, Y; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Ress, C; Lechleitner, M; Aberer, F; Mader, JK; Sourij, H; Toplak, H; Paulweber, B; Stechemesser, L; Pieber, T; Prager, R; Stingl, H; Stulnig, T; Rami-Merhar, B; Drexel, H; Roden, M; Schelkshorn, C; Wascher, TC; Weitgasser, R; Zlamal-Fortunat, S [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 32-44. Doi: 10.1007/s00508-023-02186-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Clodi, M; Toplak, H; Resl, M; Brix, J; Leitner, DR; Harreiter, J; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B [Obesity and type 2 diabetes (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 91-97. Doi: 10.1007/s00508-023-02184-6 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klammer, C; Schindler, K; Bugl, R; Plazek, D; Vötter, M; Kirchner, T; Martino, C; Klammer-Martin, J; Brix, J; Dämon, S; Hoppichler, F; Kautzky-Willer, A; Kruschitz, R; Toplak, H; Clodi, M; Ludvik, B [Nutrition for diabetic patients (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 62-77. Doi: 10.1007/s00508-023-02170-y [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Lincoff, AM; Brown-Frandsen, K; Colhoun, HM; Deanfield, J; Emerson, SS; Esbjerg, S; Hardt-Lindberg, S; Hovingh, GK; Kahn, SE; Kushner, RF; Lingvay, I; Oral, TK; Michelsen, MM; Plutzky, J; Tornøe, CW; Ryan, DH, , SELECT, Trial, Investigators Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes.
N Engl J Med. 2023; 389(24): 2221-2232. Doi: 10.1056/NEJMoa2307563
Web of Science PubMed FullText FullText_MUG

 

** Moissl, AP; Lorkowski, S; Meinitzer, A; Pilz, S; Scharnagl, H; Delgado, GE; Kleber, ME; Krämer, BK; Pieske, B; Grübler, MR; Brussee, H; von, Lewinski, D; Toplak, H; Fahrleitner-Pammer, A; März, W; Tomaschitz, A Association of branched-chain amino acids with mortality-the Ludwigshafen Risk and Cardiovascular Health (LURIC) study.
iScience. 2023; 26(4): 106459 Doi: 10.1016/j.isci.2023.106459 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Nissen, SE; Lincoff, AM; Brennan, D; Ray, KK; Mason, D; Kastelein, JJP; Thompson, PD; Libby, P; Cho, L; Plutzky, J; Bays, HE; Moriarty, PM; Menon, V; Grobbee, DE; Louie, MJ; Chen, CF; Li, N; Bloedon, L; Robinson, P; Horner, M; Sasiela, WJ; McCluskey, J; Davey, D; Fajardo-Campos, P; Petrovic, P; Fedacko, J; Zmuda, W; Lukyanov, Y; Nicholls, SJ, , CLEAR, Outcomes, Investigators Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients.
N Engl J Med. 2023; 388(15): 1353-1364. Doi: 10.1056/NEJMoa2215024
Web of Science PubMed FullText FullText_MUG

 

** Ray, KK; Haq, I; Bilitou, A; Manu, MC; Burden, A; Aguiar, C; Arca, M; Connolly, DL; Eriksson, M; Ferrières, J; Laufs, U; Mostaza, JM; Nanchen, D; Rietzschel, E; Strandberg, T; Toplak, H; Visseren, FLJ; Catapano, AL, , SANTORINI, Study, Investigators Treatment gaps in the implementation of LDL cholesterol control among high- and very high-risk patients in Europe between 2020 and 2021: the multinational observational SANTORINI study.
Lancet Reg Health Eur. 2023; 29: 100624 Doi: 10.1016/j.lanepe.2023.100624 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Toplak, H; Bilitou, A; Alber, H; Auer, J; Clodi, M; Ebenbichler, C; Fließer-Görzer, E; Gelsinger, C; Hanusch, U; Ludvik, B; Maca, T; Schober, A; Sock, R; Speidl, WS; Stulnig, TM; Weitgasser, R; Zirlik, A; Koch, M; Wienerroither, S; Wolowacz, SE; Diamand, F; Catapano, AL Simulation of bempedoic acid and ezetimibe in the lipid-lowering treatment pathway in Austria using the contemporary SANTORINI cohort of high and very high risk patients.
Wien Klin Wochenschr. 2023; 135(13-14): 364-374. Doi: 10.1007/s00508-023-02221-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Wascher, TC; Paulweber, B; Toplak, H; Saely, CH; Drexel, H; Föger, B; Hoppichler, F; Stulnig, T; Stingl, H; Clodi, M, , Ausschuss, Leitlinien [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2023)].
Wien Klin Wochenschr. 2023; 135(Suppl 1): 157-160. Doi: 10.1007/s00508-023-02166-8 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Fallbericht

** Fabian, E; Reisinger, A; Ribitsch, W; Stadlbauer, V; Eherer, AJ; Roller-Wirnsberger, R; Toplak, H; Fickert, P; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 175: A 54-year-old man with hyponatremia and delirium after surgery for a prolapsed disc.
Wien Klin Wochenschr. 2023; 135(7-8):203-209 Doi: 10.1007/s00508-022-02097-w (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Innerhofer, R; Ebenbichler, C; Baumgartner-Kaut, M; Esterbauer, H; Fasching, P; Ferch, M; Galli, L; Greber-Platzer, S; Höllerl, F; Huber, K; Karall, D; Kleemann, L; Ludvik, B; Mäser, M; Rega-Kaun, G; Scholl-Buergi, S; Speidl, W; Stulnig, T; Stögerer-Lanzenberger, M; Toplak, H; Widhalm, K; Winhofer-Stöckl, Y; Witsch-Baumgartner, M; Dieplinger, H; Binder, C CHARACTERISTICS AND MANAGEMENT OF INDIVIDUALS WITH FAMILIAL HYPERCHOLESTEROLEMIA IN AUSTRIA - DATA FROM THE NATIONAL FH-REGISTRY
ATHEROSCLEROSIS. 2023; 379: S115-S115.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

** Moissl, A; Lorkowski, S; Meinitzer, A; Pilz, S; Scharnagl, H; Delgado, G; Kleber, M; Krämer, B; Pieske, B; Grübler, M; Brussee, H; Von Lewinski, D; Toplak, H; Fahrleitner-Pammer, A; März, W; Tomaschitz, A HEAT FAILURE WITH PRESERVED EJECTION FRACTION. ASSOCIATION OF BRANCHED-CHAIN AMINO ACIDS WITH MORTALITY RISK IN THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
ATHEROSCLEROSIS. 2023; 379: S140-S140.-91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

** Ray, K; Aguiar, C; Arca, M; Connolly, D; Eriksson, M; Ferrieres, J; Laufs, U; Mostaza, J; Nanchen, D; Blackburn, C; Soronen, J; Lamparter, M; Rietzschel, E; Strandberg, T; Toplak, H; Visseren, F; Catapano, A LIPID MANAGEMENT IN PATIENTS WITH HIGH AND VERY HIGH CARDIOVASCULAR RISK: DATA FROM ROUTINE CLINICAL PRACTICE IN EUROPE (SANTORINI STUDY)
ATHEROSCLEROSIS. 2023; 379: -91st Annual Meeting of the European-Atherosclerosis-Society (EAS); MAY 21-24, 2023; Mannheim, GERMANY. [Poster]
Web of Science

 

2022

Originalarbeit (Zeitschrift)

** Kempf, K; Röhling, M; Banzer, W; Braumann, KM; Halle, M; Schaller, N; McCarthy, D; Predel, HG; Schenkenberger, I; Tan, S; Toplak, H; Martin, S; Berg, A; Acoorh, Study, Group Early and Strong Leptin Reduction Is Predictive for Long-Term Weight Loss during High-Protein, Low-Glycaemic Meal Replacement-A Subanalysis of the Randomised-Controlled ACOORH Trial.
Nutrients. 2022; 14(12): 2537 Doi: 10.3390/nu14122537 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kempf, K; Röhling, M; Banzer, W; Braumann, KM; Halle, M; Schaller, N; McCarthy, D; Predel, HG; Schenkenberger, I; Tan, S; Toplak, H; Martin, S; Berg, A; On, Behalf, Of, The, Acoorh, Study, Group High-Protein, Low-Glycaemic Meal Replacement Improves Physical Health-Related Quality of Life in High-Risk Persons for Metabolic Syndrome-A Subanalysis of the Randomised-Controlled ACOORH Trial.
NUTRIENTS. 2022; 14(15): Doi: 10.3390/nu14153161 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; März, W; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G Short-Term Treatment with Alirocumab, Flow-Dependent Dilatation of the Brachial Artery and Use of Magnetic Resonance Diffusion Tensor Imaging to Evaluate Vascular Structure: An Exploratory Pilot Study.
Biomedicines. 2022; 10(1): Doi: 10.3390/biomedicines10010152 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Metzner, T; Leitner, DR; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Reishofer, G; März, W; Landmesser, U; Scharnagl, H; Toplak, H; Silbernagel, G Effects of Alirocumab on Triglyceride Metabolism: A Fat-Tolerance Test and Nuclear Magnetic Resonance Spectroscopy Study.
Biomedicines. 2022; 10(1): Doi: 10.3390/biomedicines10010193 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Röhling, M; Kempf, K; Banzer, W; Braumann, KM; Führer-Sakel, D; Halle, M; McCarthy, D; Martin, S; Scholze, J; Toplak, H; Berg, A; Predel, HG; Acoorh, Study, Group A High-Protein and Low-Glycemic Formula Diet Improves Blood Pressure and Other Hemodynamic Parameters in High-Risk Individuals.
NUTRIENTS. 2022; 14(7): Doi: 10.3390/nu14071443 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Micic, DD; Toplak, H; Micic, DD; Polovina, SP Reproductive outcomes after bariatric surgery in women.
Wien Klin Wochenschr. 2022; 134(1-2):56-62 Doi: 10.1007/s00508-021-01986-w [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ebenbichler, C; Toplak, H; Drexel, H; Hanusch, U; Bridges, I; Dhalwani, N; Hemetsberger, M; Pigard, N Final results of the Austrian cohort of the pan-European observational study -HEYMANS
WIEN KLIN WOCHENSCHR. . 2022; 134(SUPPL 4):239-240.-ÖDG Jahrestagung; Nov 17-19, 2022; Salzburg. [Poster]
Web of Science

 

2021

Originalarbeit (Zeitschrift)

** Halle, M; Röhling, M; Banzer, W; Braumann, KM; Kempf, K; McCarthy, D; Schaller, N; Predel, HG; Scholze, J; Führer-Sakel, D; Toplak, H; Berg, A Meal replacement by formula diet reduces weight more than a lifestyle intervention alone in patients with overweight or obesity and accompanied cardiovascular risk factors-the ACOORH trial.
Eur J Clin Nutr. 2021; 75(4):661-669 Doi: 10.1038/s41430-020-00783-4 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kempf, K; Röhling, M; Banzer, W; Braumann, KM; Halle, M; McCarthy, D; Predel, HG; Schenkenberger, I; Tan, S; Toplak, H; Berg, A; Martin, S; On, Behalf, Of, Acoorh, Study, Group High-Protein, Low-Glycaemic Meal Replacement Decreases Fasting Insulin and Inflammation Markers-A 12-Month Subanalysis of the ACOORH Trial.
NUTRIENTS. 2021; 13(5): Doi: 10.3390/nu13051433 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Ray, KK; Haq, I; Bilitou, A; Aguiar, C; Arca, M; Connolly, DL; Eriksson, M; Ferrieres, J; Hildebrandt, P; Laufs, U; Mostaza, JM; Nanchen, D; Rietzschel, E; Strandberg, T; Toplak, H; Visseren, FLJ; Catapano, AL Evaluation of contemporary treatment of high- and very high-risk patients for the prevention of cardiovascular events in Europe-Methodology and rationale for the multinational observational SANTORINI study
ATHEROSCLER PLUS. 2021; 43: 24-30. Doi: 10.1016/j.athplu.2021.08.003
Web of Science FullText FullText_MUG

 

** Röhling, M; Stensitzky, A; Oliveira, CLP; Beck, A; Braumann, KM; Halle, M; Führer-Sakel, D; Kempf, K; McCarthy, D; Predel, HG; Schenkenberger, I; Toplak, H; Berg, A Effects of a Protein-Rich, Low-Glycaemic Meal Replacement on Changes in Dietary Intake and Body Weight Following a Weight-Management Intervention-The ACOORH Trial.
Nutrients. 2021; 13(2): Doi: 10.3390/nu13020376 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Toplak, H; Troester, N; Stadlbauer, V New insights in obesity development and possible value of microbiota transplantation.
Eur J Intern Med. 2021; 92:1-2 Doi: 10.1016/j.ejim.2021.06.017
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ebenbichler, C; Drexel, H; Hanusch, U; Hemetsberger, M; Pigard, N; Toplak, H Evolocumab in clinical Practice in Austria: Interim Data on LDL-C Goal Attainment from the European non-interventional HEYMANS Study
WIEN KLIN WOCHENSCHR. 2021; 133(SUPPL 6):203-204.-ÖDG Jahrestagung; Nov 18-20, 2021; Salzburg/WEB. [Poster]
Web of Science

 

** Metzner, T; Leitner, DR; Dimsity, G; Gunzer, F; Opriessnig, P; Mellitzer, K; Beck, A; Sourij, H; Stojakovic, T; Deutschmann, H; Arz, WM; Landmesser, U; Brodmann, M; Reishofer, G; Scharnagl, H; Toplak, H; Silbernagel, G SHORT-TERM EFFECTS OF INTENSIVE LDL-CHOLESTEROL LOWERING WITH ALIROCUMAB ON VASCULAR STRUCTURE AND FUNCTION
ATHEROSCLEROSIS. 2021; 331: E228-E228. [Poster]
Web of Science

 

2020

Originalarbeit (Zeitschrift)

** Huber, K; Drexel, H; Alber, H; Auer, J; Delle Karth, G; Ebenbichler, C; Fasching, P; Globits, S; Hodl, R; Hoppichler, F; Lang, W; Ludvik, B; Metzler, B; Podczeck-Schweighofer, A; Roithinger, FX; Saely, CH; Schernthaner, GH; Silbernagel, G; Siostrzonek, P; Speidl, S; Stulnig, T; Toplak, H; Vonbank, A; Wascher, T; Weidinger, F; Zweiker, R Practical realization of ESC-Guidelines to reduce LDL-cholesterol.
J KARDIOL. 2020; 27(5): 181-187.
Web of Science

 

** Leitner, DR; Toplak, H; Kedenko, L; Steinmaurer, T; Gräff, V; Metzner, T; Schwaiger, EM; Prager, R Efficacy and tolerability of alirocumab in Austrian clinical practice - results of the non-interventional PEARL-AT study.
Curr Med Res Opin. 2020; 1-1. Doi: 10.1080/03007995.2020.1786678 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Pasquali, R; Casanueva, F; Haluzik, M; van Hulsteijn, L; Ledoux, S; Monteiro, MP; Salvador, J; Santini, F; Toplak, H; Dekkers, OM European Society of Endocrinology Clinical Practice Guideline: Endocrine work-up in obesity.
Eur J Endocrinol. 2020; 182(1): G1-G32. Doi: 10.1530/EJE-19-0893 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Röhling, M; Kempf, K; Banzer, W; Berg, A; Braumann, KM; Tan, S; Halle, M; McCarthy, D; Pinget, M; Predel, HG; Scholze, J; Toplak, H; Martin, S; Acoorh Study Group, S Prediabetes Conversion to Normoglycemia Is Superior Adding a Low-Carbohydrate and Energy Deficit Formula Diet to Lifestyle Intervention-A 12-Month Subanalysis of the ACOORH Trial.
Nutrients. 2020; 12(7): Doi: 10.3390/nu12072022 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** van Hulsteijn, LT; Pasquali, R; Casanueva, F; Haluzik, M; Ledoux, S; Monteiro, MP; Salvador, J; Santini, F; Toplak, H; Dekkers, OM Prevalence of endocrine disorders in obese patients: systematic review and meta-analysis.
Eur J Endocrinol. 2020; 182(1):11-21 Doi: 10.1530/EJE-19-0666
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ebenbichler, C; Drexel, H; Hanusch, U; Hemetsberger, M; Holzl, R; Toplak, H Evolocumab in clinical Practice in Austria: Interim Data on the Achievement of LDL-C-Target Values from the European, non-interventional HEYMANS-Study.
WIEN KLIN WOCHENSCHR. 2020; 132: S342-S342. [Poster]
Web of Science

 

2019

Originalarbeit (Zeitschrift)

** Durrer Schutz, D; Busetto, L; Dicker, D; Farpour-Lambert, N; Pryke, R; Toplak, H; Widmer, D; Yumuk, V; Schutz, Y European Practical and Patient-Centred Guidelines for Adult Obesity Management in Primary Care.
Obes Facts. 2019; 12(1):40-66 Doi: 10.1159/000496183 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Frühbeck, G; Busetto, L; Dicker, D; Yumuk, V; Goossens, GH; Hebebrand, J; Halford, JGC; Farpour-Lambert, NJ; Blaak, EE; Woodward, E; Toplak, H The ABCD of Obesity: An EASO Position Statement on a Diagnostic Term with Clinical and Scientific Implications.
Obes Facts. 2019; 12(2):131-136 Doi: 10.1159/000497124 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Kautzky, A; Hofmann, P; Toplak, H [Mental disorders and diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):186-195 Doi: 10.1007/s00508-019-1458-9
Web of Science PubMed FullText FullText_MUG

 

** Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Antihyperglycemic treatment guidelines for diabetes mellitus type 2 (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):27-38 Doi: 10.1007/s00508-019-1471-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Lechleitner, M; Clodi, M; Abrahamian, H; Brath, H; Brix, J; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Fröhlich-Reiterer, E; Harreiter, J; Hofer, SE; Hoppichler, F; Huber, J; Kaser, S; Kautzky-Willer, A; Ludvik, B; Luger, A; Mader, JK; Paulweber, B; Pieber, T; Prager, R; Rami-Merhar, B; Resl, M; Riedl, M; Roden, M; Saely, CH; Schelkshorn, C; Schernthaner, G; Sourij, H; Stechemesser, L; Stingl, H; Toplak, H; Wascher, TC; Weitgasser, R; Winhofer-Stöckl, Y; Zlamal-Fortunat, S [Insulin therapy of type 2 diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):39-46 Doi: 10.1007/s00508-019-1492-7
Web of Science PubMed FullText FullText_MUG

 

** Schindler, K; Brix, J; Dämon, S; Hoppichler, F; Kautzky-Willer, A; Kruschitz, R; Toplak, H; Ludvik, B [Nutrition for diabetic patients (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):54-60 Doi: 10.1007/s00508-019-1470-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Toplak, H; Leitner, DR; Harreiter, J; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B ["Diabesity"-Obesity and type 2 diabetes (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):71-76 Doi: 10.1007/s00508-018-1418-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Paulweber, B; Toplak, H; Saely, CH; Drexel, H; Föger, B; Hoppichler, F; Stulnig, T; Stingl, H; Clodi, M; den Ausschuss Leitlinien [Lipids-Diagnosis and therapy in diabetes mellitus (Update 2019)].
Wien Klin Wochenschr. 2019; 131(Suppl 1):136-138 Doi: 10.1007/s00508-019-1444-2
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Ebenbichler, C; Kedenko, L; Hanusch, U; Sourij, H; Drexel, H; Prager, R; Hemetsberger, M; Ratzinger, M; Toplak, H Evolocumab in clinical Practice in Austria in Comparison to Total Evaluation from 10 Countries: 12-Month Interim Data
WIEN KLIN WOCHENSCHR. 2019; 131(SUPPL 5):S465-S466. [Poster]
Web of Science

 

** Guttmann, A; Horist-Kollmann, SM; Prenner, C; Deutsch, A; Kristoferitsch, M; Krautsack, A; Wappl, E; Thauerer, WKB; Toplak, H; Strametz-Juranek, J Malnutrition - Influence and Outcome in cardiovascular Rehabilitation: Pilot Study
WIEN KLIN WOCHENSCHR. Abstracts, Österreichische Kardiologische Gesellschaft Jahrestagung 2019, mit Beteiligung der Österreichischen Gesellschaft für Herzchirurgie und thorakale Gefäßchirurgie.. 2019; 131: 298-299. [Poster]
Web of Science FullText

 

** Paumann, R; Moyses, K; Toplak, H Does the Completion of the 6-to 9-month Program "Vorsorge Aktiv - Lebensstilmedizin" lead to a Change in Performance that can be proven in Ergometer Tests?
WIEN KLIN WOCHENSCHR. Abstracts 47. Jahrestagung der Österreichischen Diabetes Gesellschaft. 2019; 131(SUPPL 5):S461-S461.-47. Jahrestagung der Österreichischen Diabetes Gesellschaft; NOV 21-23, 2019; Salzburg, Austria. [Poster]
Web of Science

 

2018

Originalarbeit (Zeitschrift)

** Barazzoni, R; Bischoff, S; Boirie, Y; Busetto, L; Cederholm, T; Dicker, D; Toplak, H; Van Gossum, A; Yumuk, V; Vettor, R Sarcopenic Obesity: Time to Meet the Challenge.
OBESITY FACTS. 2018; 11(4): 294-305. Doi: 10.1159/000490361 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Barazzoni, R; Bischoff, SC; Boirie, Y; Busetto, L; Cederholm, T; Dicker, D; Toplak, H; Van Gossum, A; Yumuk, V; Vettor, R Sarcopenic obesity: Time to meet the challenge.
Clin Nutr. 2018; 37(6 Pt A):1787-1793 Doi: 10.1016/j.clnu.2018.04.018 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Busetto, L; Dicker, D; Azran, C; Batterham, RL; Farpour-Lambert, N; Fried, M; Hjelmesæth, J; Kinzl, J; Leitner, DR; Makaronidis, JM; Schindler, K; Toplak, H; Yumuk, V Obesity Management Task Force of the European Association for the Study of Obesity Released "Practical Recommendations for the Post-Bariatric Surgery Medical Management".
Obes Surg. 2018; 28(7):2117-2121 Doi: 10.1007/s11695-018-3283-z
Web of Science PubMed FullText FullText_MUG

 

** Ferrières, J; Lautsch, D; Gitt, AK; De Ferrari, G; Toplak, H; Elisaf, M; Drexel, H; Horack, M; Baxter, C; Ambegaonkar, B; Brudi, P; Toth, PP Body mass index impacts the choice of lipid-lowering treatment with no correlation to blood cholesterol - Findings from 52 916 patients in the Dyslipidemia International Study (DYSIS).
Diabetes Obes Metab. 2018; 20(11):2670-2674 Doi: 10.1111/dom.13415 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Kotsis, V; Jordan, J; Micic, D; Finer, N; Leitner, DR; Toplak, H; Tokgozoglu, L; Athyros, V; Elisaf, M; Filippatos, TD; Redon, J; Redon, P; Antza, C; Tsioufis, K; Grassi, G; Seravalle, G; Coca, A; Sierra, C; Lurbe, E; Stabouli, S; Jelakovic, B; Nilsson, PM Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part A: mechanisms of obesity induced hypertension, diabetes and dyslipidemia and practice guidelines for treatment.
J Hypertens. 2018; 36(7):1427-1440 Doi: 10.1097/HJH.0000000000001730
Web of Science PubMed FullText FullText_MUG

 

** Kotsis, V; Tsioufis, K; Antza, C; Seravalle, G; Coca, A; Sierra, C; Lurbe, E; Stabouli, S; Jelakovic, B; Redon, J; Redon, P; Nilsson, PM; Jordan, J; Micic, D; Finer, N; Leitner, DR; Toplak, H; Tokgozoglu, L; Athyros, V; Elisaf, M; Filippatos, TD; Grassi, G Obesity and cardiovascular risk: a call for action from the European Society of Hypertension Working Group of Obesity, Diabetes and the High-risk Patient and European Association for the Study of Obesity: part B: obesity-induced cardiovascular disease, early prevention strategies and future research directions.
J Hypertens. 2018; 36(7):1441-1455 Doi: 10.1097/HJH.0000000000001731
Web of Science PubMed FullText FullText_MUG

 

** Schusterbauer, V; Feitek, D; Kastner, P; Toplak, H Two-Stage Evaluation of a Telehealth Nutrition Management Service in Support of Diabesity Therapy.
Stud Health Technol Inform. 2018; 248: 314-321.
PubMed

 

Fallbericht

** Fabian, E; Schiller, D; Toplak, H; Brunner-Krainz, M; Fazekas, F; Schoefl, R; Krejs, GJ Clinical-Pathological Conference Series from the Medical University of Graz : Case No 153: A 55-year-old woman with atypical multiple sclerosis and irritable bowel syndrome.
Wien Klin Wochenschr. 2018; 130(3-4):151-160 Doi: 10.1007/s00508-017-1291-y (- Case Report) [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Drexel, H; Toplak, H; Hanusch, U; Prager, R; Sourij, H; Hemetsberger, M; Ratzinger, M; Ebenbichler, C Evolocumab in clinical Practice in Austria: 6 Months Interim Data on Patient Characteristics, Efficacy and Tolerability from a European, non-interventional Study
WIEN KLIN WOCHENSCHR. 2018; 130: 359-360. [Poster]
Web of Science

 

2017

Originalarbeit (Zeitschrift)

** Busetto, L; Dicker, D; Azran, C; Batterham, RL; Farpour-Lambert, N; Fried, M; Hjelmesæth, J; Kinzl, J; Leitner, DR; Makaronidis, JM; Schindler, K; Toplak, H; Yumuk, V Practical Recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management.
Obes Facts. 2017; 10(6):597-632 Doi: 10.1159/000481825 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Hebebrand, J; Holm, JC; Woodward, E; Baker, JL; Blaak, E; Durrer Schutz, D; Farpour-Lambert, NJ; Frühbeck, G; Halford, JGC; Lissner, L; Micic, D; Mullerova, D; Roman, G; Schindler, K; Toplak, H; Visscher, TLS; Yumuk, V A Proposal of the European Association for the Study of Obesity to Improve the ICD-11 Diagnostic Criteria for Obesity Based on the Three Dimensions Etiology, Degree of Adiposity and Health Risk.
Obes Facts. 2017; 10(4): 284-307. Doi: 10.1159/000479208 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Tribolet, P; Fehr, R; Bachli, V; Geiser, M; Toplak, H; Stanga, Z; Schuetz, P What are Barriers of Nutritional Therapy in Malnourished Medical Inpatients? An Observational Study
AKTUEL ERNAHRUNGSMED. 2017; 42(3): 167-179. Doi: 10.1055/s-0043-109233
Web of Science FullText FullText_MUG

 

Übersichtsarbeit

** Leitner, DR; Frühbeck, G; Yumuk, V; Schindler, K; Micic, D; Woodward, E; Toplak, H Obesity and Type 2 Diabetes: Two Diseases with a Need for Combined Treatment Strategies - EASO Can Lead the Way.
Obes Facts. 2017; 10(5):483-492 Doi: 10.1159/000480525 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Editorial

** Siegert, C; Konrad, M; Wallner, M; Toplak, H; Pail, E Table Vinegar: (patho-) physiological Effects
ERNAHRUNGS UMSCHAU. 2017; 64(10): M594-M595.
Web of Science

 

2016

Originalarbeit (Zeitschrift)

** Clodi, M; Abrahamian, H; Drexel, H; Fasching, P; Föger, B; Francesconi, C; Hoppichler, F; Kaser, S; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Fröhlich-Reiterer, E; Roden, M; Säly, C; Schernthaner, G; Sourij, H; Toplak, H; Wascher, TC; Weitgasser, R [Antihyperglycemic treatment guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S45-S53 Doi: 10.1007/s00508-016-0991-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Frühbeck, G; Sbraccia, P; Nisoli, E; Woodward, E; Yumuk, V; Farpour-Lambert, NJ; Halford, JG; Toplak, H; Carruba, MO 2015 Milan Declaration: A Call to Action on Obesity - an EASO Position Statement on the Occasion of the 2015 EXPO.
Obes Facts. 2016; 9(4):296-298 Doi: 10.1159/000448234 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Jordan, J; Toplak, H; Grassi, G; Yumuk, V; Kotsis, V; Engeli, S; Cuspidi, C; Nilsson, PM; Finer, N; Doehner, W Joint statement of the European Association for the Study of Obesity and the European Society of Hypertension: obesity and heart failure.
J Hypertens. 2016; 34(9):1678-1688 Doi: 10.1097/HJH.0000000000001013
Web of Science PubMed FullText FullText_MUG

 

** Toplak, H The pharmacolocial management of obesity
AUST J CLIN ENDOCR M. 2016; 9(2): 43-45. [OPEN ACCESS]
Web of Science

 

** Toplak, H; Ludvik, B; Lechleitner, M; Dieplinger, H; Föger, B; Paulweber, B; Weber, T; Watschinger, B; Horn, S; Wascher, TC; Drexel, H; Brodmann, M; Pilger, E; Rosenkranz, A; Pohanka, E; Oberbauer, R; Traindl, O; Roithinger, FX; Metzler, B; Haring, HP; Kiechl, S Austrian Lipid Consensus on the management of metabolic lipid disorders to prevent vascular complications: A joint position statement issued by eight medical societies. 2016 update.
Wien Klin Wochenschr. 2016; 128 Suppl 2(5):S216-S228 Doi: 10.1007/s00508-016-0993-x [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Hofmann, P; Toplak, H [Mental disorders and diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S170-S178 Doi: 10.1007/s00508-015-0939-8 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Schindler, K; Brix, J; Dämon, S; Hoppichler, F; Kruschitz, R; Toplak, H; Ludvik, B [Nutrition for diabetic patients].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S131-S136 Doi: 10.1007/s00508-015-0926-0 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Toplak, H; Hoppichler, F; Wascher, TC; Schindler, K; Ludvik, B [Obesity and type 2 diabetes].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S196-S200 Doi: 10.1007/s00508-016-0986-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Paulweber, B; Toplak, H; Säly, CH; Drexel, H; Föger, B; Hoppichler, F [Lipids--Diagnosis and therapy in diabetes mellitus].
Wien Klin Wochenschr. 2016; 128 Suppl 2(4):S68-S70 Doi: 10.1007/s00508-015-0933-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Berg, A; Koohkan, S; Banzer, W; Braumann, KM; Fuhrer-Sakel, D; Halle, M; Martin, S; Predel, HG; Toplak, H THE ALMASED CONCEPT AGAINST OVERWEIGHT AND OBESITY AND RELATED HEALTH RISK (ACOORH)-FIRST RESULTS OF AN INTERIM ANALYSIS
DIABETES TECHNOL THE. 2016; 18: A131-A132. [Poster]
Web of Science

 

Kommentar

** Hainer, V; Tsigos, C; Toplak, H; Micic, D Comment on the Paper by Uerlich et al: Obesity Management in Europe: Current Status and Objectives for the Future. Obes Facts 2016;9:273-283.
Obes Facts. 2016; 9(6):392-396 Doi: 10.1159/000452249 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Toplak, H; Stauber, R; Sourij, H EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: guidelines, clinical reality and health economic aspects.
Diabetologia. 2016; 59(6):1148-1149 Doi: 10.1007/s00125-016-3941-4 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Originalarbeit (Zeitschrift)

** Chmelar, S; Temmel, A; Kier, P; Toplak, H; Pail, E Olfactory Disorders in Oncology - An Overview
ERNAHRUNGS UMSCHAU. 2015; 62(1): M14-M19. Doi: 10.4455/eu.2015.002
Web of Science FullText FullText_MUG

 

** Tomaschitz, A; Piecha, G; Ritz, E; Meinitzer, A; Haas, J; Pieske, B; Wiecek, A; Rus-Machan, J; Toplak, H; März, W; Verheyen, N; Gaksch, M; Amrein, K; Kraigher-Krainer, E; Fahrleitner-Pammer, A; Pilz, S Marinobufagenin in essential hypertension and primary aldosteronism: a cardiotonic steroid with clinical and diagnostic implications.
Clin Exp Hypertens. 2015; 37(2):108-15 Doi: 10.3109/10641963.2014.913604
Web of Science PubMed FullText FullText_MUG

 

** Tomaschitz, A; Pilz, S; Rus-Machan, J; Meinitzer, A; Brandenburg, VM; Scharnagl, H; Kapl, M; Grammer, T; Ritz, E; Horina, JH; Kleber, ME; Pieske, B; Kraigher-Krainer, E; Hartaigh, BÓ; Toplak, H; van Ballegooijen, AJ; Amrein, K; Fahrleitner-Pammer, A; März, W Interrelated aldosterone and parathyroid hormone mutually modify cardiovascular mortality risk.
Int J Cardiol. 2015; 184(9):710-716 Doi: 10.1016/j.ijcard.2015.03.062
Web of Science PubMed FullText FullText_MUG

 

** Toplak, H; Woodward, E; Yumuk, V; Oppert, JM; Halford, JC; Frühbeck, G 2014 EASO Position Statement on the Use of Anti-Obesity Drugs.
Obes Facts. 2015; 8(3):166-174 Doi: 10.1159/000430801 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Yumuk, V; Tsigos, C; Fried, M; Schindler, K; Busetto, L; Micic, D; Toplak, H; Obesity Management Task Force of the European Association for the Study of Obesity European Guidelines for Obesity Management in Adults.
Obes Facts. 2015; 8(6):402-424 Doi: 10.1159/000442721 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Jordan, J; Nilsson, PM; Kotsis, V; Olsen, MH; Grassi, G; Yumuk, V; Hauner, H; Zahorska-Markiewicz, B; Toplak, H; Engeli, S; Finer, N Joint scientific statement of the European Association for the Study of Obesity and the European Society of Hypertension: Obesity and early vascular ageing.
J Hypertens. 2015; 33(3):425-434 Doi: 10.1097/HJH.0000000000000473
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Ots, T; Toplak, H Interview with Univ. Prof. Dr. Hermann Toplak to issues of food
DTSCH Z AKUPUNKT. 2015; 58(1): 14-17. Doi: 10.1016/S0415-6412(15)60005-4
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Berg, A; Koohkan, S; Kempf, K; Martin, S; McCarthy, D; Toplak, H THE ALMASED CONCEPT AGAINST OVERWEIGHT AND OBESITY AND RELATED HEALTH RISK (ACOORH) HAS STARTED
DIABETES TECHNOL THE. 2015; 17: A141-A142. [Poster]
Web of Science

 

2014

Originalarbeit (Zeitschrift)

** Frühbeck, G; Toplak, H; Woodward, E; Halford, JC; Yumuk, V; European Association for the Study of Obesity Need for a paradigm shift in adult overweight and obesity management - an EASO position statement on a pressing public health, clinical and scientific challenge in Europe.
Obes Facts. 2014; 7(6):408-416 Doi: 10.1159/000370038 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Garvey, WT; Ryan, DH; Henry, R; Bohannon, NJ; Toplak, H; Schwiers, M; Troupin, B; Day, WW Prevention of type 2 diabetes in subjects with prediabetes and metabolic syndrome treated with phentermine and topiramate extended release.
Diabetes Care. 2014; 37(4):912-921 Doi: 10.2337/dc13-1518 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Klose, G; Beil, FU; Dieplinger, H; von Eckardstein, A; Föger, B; Gouni-Berthold, I; Heigl, F; Koenig, W; Kostner, GM; Landmesser, U; Laufs, U; Leistikow, F; März, W; Noll, G; Parhofer, KG; Paulweber, B; Riesen, WF; Schaefer, JR; Steinhagen-Thiessen, E; Steinmetz, A; Toplak, H; Wanner, C; Windler, E; American Heart Association, American College of Cardiology New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk.
Wien Klin Wochenschr. 2014; 126(5-6):169-175 Doi: 10.1007/s00508-014-0513-9
Web of Science PubMed FullText FullText_MUG

 

** Klose, G; Beil, FU; Dieplinger, H; von Eckardstein, A; Föger, B; Gouni-Berthold, I; Koenig, W; Kostner, GM; Landmesser, U; Laufs, U; Leistikow, F; März, W; Merkel, M; Müller-Wieland, D; Noll, G; Parhofer, KG; Paulweber, B; Riesen, W; Schaefer, JR; Steinhagen-Thiessen, E; Steinmetz, A; Toplak, H; Wanner, C; Windler, E [New AHA and ACC guidelines on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk : Statement of the D•A•CH Society for Prevention of Cardiovascular Diseases, the Austrian Atherosclerosis Society and the Working Group on Lipids and Atherosclerosis (AGLA) of the Swiss Society for Cardiology].
Internist (Berl). 2014; 55(5):601-606 Doi: 10.1007/s00108-014-3492-z [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Yumuk, V; Frühbeck, G; Oppert, JM; Woodward, E; Toplak, H An EASO position statement on multidisciplinary obesity management in adults.
Obes Facts. 2014; 7(2):96-101 Doi: 10.1159/000362191 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Übersichtsarbeit

** Tomaschitz, A; Ritz, E; Pieske, B; Rus-Machan, J; Kienreich, K; Verheyen, N; Gaksch, M; Grübler, M; Fahrleitner-Pammer, A; Mrak, P; Toplak, H; Kraigher-Krainer, E; März, W; Pilz, S Aldosterone and parathyroid hormone interactions as mediators of metabolic and cardiovascular disease.
Metabolism. 2014; 63(1):20-31 Doi: 10.1016/j.metabol.2013.08.016 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Korrektur

** Klose, G; Beil, FU; Dieplinger, H; von Eckardstein, A; Foger, B; Gouni-Berthold, I; Heigl, F; Koenig, W; Kostner, GM; Landmesser, U; Laufs, U; Leistikow, F; Marz, W; Merkel, M; Muller-Wieland, D; Noll, G; Parhofer, KG; Paulweber, B; Riesen, W; Schaefer, JR; Steinhagen-Thiessen, E; Steinmetz, A; Toplak, H; Wanner, C; Windler, E New AHA- and ACC-Guidelines for Risk Reduction of Cardio-Vascular-Disease by lowering Cholesterol. Measures of the D.A.CH-Prevention Society of Cardio-Vascular-Diseases e.V., the Austrian Atherosclerosis Society and the Study Group of Lipids and Atherosclerosis (AGLA) of the Swiss Society of Cardiology (vol 55, pg 601, 2014)
INTERNIST. 2014; 55(9): 1112-1112. Doi: 10.1007/s00108-014-3576-9 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Brath, H; Ebenbichler, C; Paulweber, B; Toplak, H; Prager, R; Ludvik, B Impact of hypoglycaemia on patient actions in the Austrian hypoglycaemia assessment tool (HAT) study cohort
WIEN KLIN WOCHENSCHR. 2014; 126: S186-S186. [Poster]
Web of Science

 

** Ludvik, B; Ebenbichler, C; Paulweber, B; Toplak, H; Brath, H; Prager, R Hypoglycaemia among insulin-treated patients with diabetes: Austrian results from the international hypoglycaemia assessment tool (HAT) study
WIEN KLIN WOCHENSCHR. 2014; 126: S185-S186. [Poster]
Web of Science

 

2013

Originalarbeit (Zeitschrift)

** Frühbeck, G; Toplak, H; Woodward, E; Yumuk, V; Maislos, M; Oppert, JM; Executive Committee of the European Association for the Study of Obesity Obesity: the gateway to ill health - an EASO position statement on a rising public health, clinical and scientific challenge in Europe.
Obes Facts. 2013; 6(2):117-120 Doi: 10.1159/000350627 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Pichler, M; Lautsch, D; Adler, C; Bögl, K; Drexel, H; Eber, B; Fauer, C; Föchterle, J; Föger, B; Gansch, K; Grafinger, P; Lechleitner, M; Ludvik, B; Maurer, G; Mörz, R; Paulweber, B; Pfeiffer, KP; Prager, R; Stark, G; Toplak, H; Traindl, O; Weitgasser, R Are there differences in LDL-C target value attainment in Austrian federal states? Yes!
Wien Med Wochenschr. 2013; 163(23-24):528-535 Doi: 10.1007/s10354-013-0219-z [OPEN ACCESS]
PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Feitek, D; Kastner, P; Toplak, H; Pail, E; Pilot Study: "Feasibility and Acceptance of a tele-dietetic Intervention in Patients with Type-2-Diabetes mellitus without Insulin Therapy".
WIEN KLIN WOCHENSCHR. . 2013; 125(17-18):545-545. [Poster]
Web of Science

 

** Galler, M; Konrad, M; Grach, D; Toplak, H; Pail, E; Differences in Nutrition Behavior between the regular rotating Shift Workers compared with the irregular Shift Workers, the Example of Persons insured with the Insurance Company for Railways and Mining.
WIEN KLIN WOCHENSCHR. . 2013; 125(17-18):547-547. [Poster]
Web of Science

 

** Haring, A; Roller-Wirnsberger, R; Neugebauer, H; Toplak, H; Pail, E; What simple, practical Methods are appropriate in a clinical Setting for the Diagnosis of Sarcopenia in Elderly Patients who have fallen?.
WIEN KLIN WOCHENSCHR. . 2013; 125(17-18):564-564. [Poster]
Web of Science

 

** Toplak, H; Rossner, S; Dvorak, R Effects of phentermine and topiramate extended-release (PHEN/TPM ER) on weight loss (WL) and glycaemic parameters by gender, race, and baseline body mass index (BMI)
DIABETOLOGIA. . 2013; 56: S259-S259.-49th Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD); SEP 23-27, 2013; Barcelona, SPAIN. [Poster]
Web of Science

 

2012

Originalarbeit (Zeitschrift)

** Abrahamian, H; Hofmann, P; Kinzl, J; Toplak, H Diabetes mellitus and comorbid depression: improvement of both diseases with milnacipran. A replication study (results of the Austrian Major Depression Diabetes Mellitus study group).
Neuropsychiatr Dis Treat. 2012; 8(8):355-360 Doi: 10.2147/NDT.S33679 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Abrahamian, H; Kautzky-Willer, A; Rießland-Seifert, A; Fasching, P; Ebenbichler, C; Hofmann, P; Toplak, H Mental disorders and diabetes mellitus].
Wien Klin Wochenschr. 2012; 124 Suppl 2(12):107-114 Doi: 10.1007/s00508-012-0279-x
Web of Science PubMed FullText FullText_MUG

 

** Brath, H; Wascher, TC; Kästenbauer, T; Toplak, H Screening for hyperlipidemia in cardiovascular high-risk patients in austrian diabetes ambulances.
MMW Fortschr Med. 2012; 154 Suppl 2:41-47
PubMed

 

** Clodi, M; Abrahamian, HE; Drexel, H; Fasching, P; Hoppichler, F; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Roden, M; Saely, C; Schernthaner, G; Schober, E; Toplak, H; Wascher, T; Weitgasser, R Antihyperglycemic Treatment Guidelines for diabetes mellitus type 2].
Wien Klin Wochenschr. 2012; 124 Suppl 2(4):10-16 Doi: 10.1007/s00508-012-0263-5 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mathus-Vliegen, EM; Basdevant, A; Finer, N; Hainer, V; Hauner, H; Micic, D; Maislos, M; Roman, G; Schutz, Y; Tsigos, C; Toplak, H; Yumuk, V; Zahorska-Markiewicz, B Prevalence, pathophysiology, health consequences and treatment options of obesity in the elderly: a guideline.
Obes Facts. 2012; 5(3):460-483 Doi: 10.1159/000341193 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Paulweber, B; Toplak, H; Saely, C; Drexel, H Lipids: diagnosis and therapy in type 2 diabetes].
Wien Klin Wochenschr. 2012; 124 Suppl 2(12):28-30 Doi: 10.1007/s00508-012-0273-3
Web of Science PubMed FullText FullText_MUG

 

2011

Originalarbeit (Zeitschrift)

** Tsigos, C; Hainer, V; Basdevant, A; Finer, N; Mathus-Vliegen, E; Micic, D; Maislos, M; Roman, G; Schutz, Y; Toplak, H; Yumuk, V; Zahorska-Markiewicz, B; Obesity Management Task Force of the European Association for the Study of Obesity Criteria for EASO-collaborating centres for obesity management.
Obes Facts. 2011; 4(4):329-333 Doi: 10.1159/000331236 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Zeitschrift)

** Maierhofer, S; deCampo, A; Stojakovic, T; Jahnel, H; Toplak, H EFFECTIVITY OF COLESEVELAM IN STATIN INTOLERANT PATIENTS ± EZETIMIBE.
ATHEROSCLER SUPPL. 2011; 12(1):163-163.-79th Congress of the European Atherosclerosis Society (EAS); JUN 26-29, 2011; Gothenburg, SWEDEN. Doi: 10.1016/S1567-5688(11)70779-6 [Poster]
Web of Science FullText FullText_MUG

 

2010

Abstract (Zeitschrift)

** Ederer, T; Toplak, H; Obermayer-Pietsch, B; Hammer, H; Hogenauer, C Diagnosis of lactose intolerance - Comparison of the genetic tests for primary adult lactase deficiency with lactose H2 breath test.
WIEN KLIN WOCHENSCHR. 2010; 122(17-18): A10-A10.
Web of Science

 

** Fliesser-Gorzer, E; Kellner, A; Toplak, H A Comparison of obese and Diabetic Patients regarding Weight Loss, Body Composition Measurement, Blood Glucosa Control and cardiovascular Risk Factors, between conventional Diet and the VLCD Program INSUmed
WIEN KLIN WOCHENSCHR. 2010; 122(19-20): A45-A45. [Poster]
Web of Science

 

2009

Originalarbeit (Zeitschrift)

** Abrahamian, H; Hofmann, P; Prager, R; Toplak, H Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group).
Neuropsychiatr Dis Treat. 2009; 5(2):261-266 Doi: 10.2147/NDT.S5421 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Clodi, M; Fasching, P; Hoppichler, F; Kautzky-Willer, A; Lechleitner, M; Ludvik, B; Prager, R; Roden, M; Schernthaner, G; Toplak, H; Wascher, TC; Weitgasser, R Antidiabetic therapy of type-2 diabetes
WIEN KLIN WOCHENSCHR. 2009; 121: S13-S17.
Web of Science

 

** Ludvik, B; Brath, H; Wascher, T; Toplak, H; Expertengruppe der Osterreichischen Diabetesgesellschaft The significance of long acting insulin analogues in the treatment of type 2 diabetes mellitus.
Wien Klin Wochenschr. 2009; 121(13-14): 473-482. Doi: 10.1007/s00508-009-1209-4
Web of Science PubMed FullText FullText_MUG

 

Editorial

** Toplak, H; Abrahamian, H Impact of Depression on Diabetes mellitus
OBES FACTS. 2009; 2(4): 211-215. Doi: 10.1159/000234464 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Abrahamian, H; Hofmann, P; Prager, R; Toplak, H Diabetes mellitus and co-morbid depression: treatment with Milnacipran results in significant improvement of both diseases
INT J PSYCHIATR CLIN PRACT. 2009; 13: 23-23. [Poster]
Web of Science

 

Originalarbeit (Konferenzband)

** Hainer, V; Toplak, H; Stich, V Fat or fit: what is more important?
DIABETES CARE. 2009; 32 Suppl 2(21): S392-S397. Doi: 10.2337/dc09-S346 [Oral Communication] [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2008

Originalarbeit (Zeitschrift)

** Morak, J; Schindler, K; Goerzer, E; Kastner, P; Toplak, H; Ludvik, B; Schreier, G A pilot study of mobile phone-based therapy for obese patients.
J Telemed Telecare. 2008; 14(3): 147-149. Doi: 10.1258/jtt.2008.003015
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Tsigos, C; Hainer, V; Basdevant, A; Finer, N; Fried, M; Mathus-Vliegen, E; Micic, D; Maislos, M; Roman, G; Schutz, Y; Toplak, H; Zahorska-Markiewicz, B Management of Obesity in Adults: European Clinical Practice Guidelines.
Obesity Facts The European Journal of Obesity. 2008; 1: 106-116. Doi: 10.1159/000126822 [OPEN ACCESS]
Web of Science FullText FullText_MUG

 

Abstract (Zeitschrift)

** Haslinger, S; Toplak, H; Dimai, H; Erwa, W Research on the breakdown point of extra long chain of fatty acids in patients with known to have adrenal insufficiency
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A41-A41.-Austrian Association of Internal Medicine; 17th-20th September 2008; Graz, Austria. [Poster]
Web of Science

 

** Kapp, C; Fliesser-Gorzer, E; Toplak, H Sarcopenia adiposity: Differences in a weight loss in comparison with over weighted with a normal muscle mass
WIEN KLIN WOCHENSCHR. 2008; 120(15-16):A39-A39.-Austrian Association of Internal Medicine; 17th-20th September 2008; Graz, Austria. [Poster]
Web of Science

 

Originalarbeit (Konferenzband)

** Hainer, V; Toplak, H; Mitrakou, A Treatment Modalities of Obesity What fits whom?
DIABETES CARE. 2008; 31: S269-S277. Doi: 10.2337/dc08-s265 [Oral Communication] [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2007

Originalarbeit (Zeitschrift)

** Toplak, H; Hamann, A; Moore, R; Masson, E; Gorska, M; Vercruysse, F; Sun, X; Fitchet, M Efficacy and safety of topiramate in combination with metformin in the treatment of obese subjects with type 2 diabetes: a randomized, double-blind, placebo-controlled study.
Int J Obes (Lond). 2007; 31(1): 138-146. Doi: 10.1038/sj.ijo.0803382 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** Gorzer, E; Wamser, K; Tscherner, D; Toplak, H The effect of a VLCD programme using INSUmed on fat mass in patients with BMI above 29 - a comparison of type 2 diabetic and non diabetic patients
INT J OBESITY. 2007; 31: S166-S166. [Poster]
Web of Science

 

2006

Originalarbeit (Zeitschrift)

** Hecke, K; Herbinger, K; Veberic, R; Trobec, M; Toplak, H; Stampar, F; Keppel, H; Grill, D Sugar-, acid- and phenol contents in apple cultivars from organic and integrated fruit cultivation.
Eur J Clin Nutr. 2006; 60(9): 1136-1140. Doi: 10.1038/sj.ejcn.1602430 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kopera, D; Binder, B; Toplak, H Intralesional lipolysis with phosphatidylcholine for the treatment of lipomas: pilot study.
Arch Dermatol. 2006; 142(3):395-396 Doi: 10.1001/archderm.142.3.395 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Kopera, D; Binder, B; Toplak, H; Kerl, H; Cerroni, L Histopathologic changes after intralesional application of phosphatidylcholine for lipoma reduction: report of a case.
Am J Dermatopathol. 2006; 28(4):331-333 Doi: 10.1097/00000372-200608000-00007 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Putz-Bankuti, C; Datz, C; März, W; Lackner, C; Stauber, RE; Trauner, M; Toplak, H; Stojakovic, T; Krejs, GJ Clinical-pathological conference series from the Medical University of Graz : case no. 131: elevated transaminases in a 30-year-old male.
Wien Klin Wochenschr. 2006; 118(23-24):769-775 Doi: 10.1007/s00508-006-0718-7 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Sundl, I; Pail, E; Mellitzer, K; Toplak, H; Winklhofer-Roob, BM Effects of orlistat therapy on plasma concentrations of oxygenated and hydrocarbon carotenoids
LIPIDS. 2006; 41: 113-118. Doi: 10.1007/s11745-006-5078-6
Web of Science FullText FullText_MUG

 

2005

Originalarbeit (Zeitschrift)

** Högenauer, C; Hammer, HF; Mellitzer, K; Renner, W; Krejs, GJ; Toplak, H Evaluation of a new DNA test compared with the lactose hydrogen breath test for the diagnosis of lactase non-persistence.
Eur J Gastroenterol Hepatol. 2005; 17(3):371-376 Doi: 10.1097/00042737-200503000-00018
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Ziegler, O; Keller, U; Hamann, A; Godin, C; Wittert, G; Zanella, MT; Zuniga-Guajardo, S; Van Gaal, L X-PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced-energy diet: early response to treatment predicts weight maintenance.
DIABETES OBES METAB. 2005; 7(6): 699-708. Doi: 10.1111/j.1463-1326.2005.00483.x
Web of Science PubMed FullText FullText_MUG

 

2004

Originalarbeit (Zeitschrift)

** Murkovic, M; Abuja, PM; Bergmann, AR; Zirngast, A; Adam, U; Winklhofer-Roob, BM; Toplak, H Effects of elderberry juice on fasting and postprandial serum lipids and low-density lipoprotein oxidation in healthy volunteers: a randomized, double-blind, placebo-controlled study.
EUR J CLIN NUTR. 2004; 58: 244-249. Doi: 10.1038/sj.ejcn.1601773 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Toplak, H Metabolic syndrome--a high cardiovascular risk?
ACTA MED AUST. 2004; 31(3): 63-66.
Web of Science PubMed FullText

 

Abstract (Zeitschrift)

** Jacob, S; Ziegler, O; Toplak, H Orlistat improves all components of the metabolic syndrome in overweight and obese patients on two diets
INT J OBESITY 2004 28: S154-S154.
Web of Science

 

** Keinrath, P; Mellitzer, K; Toplak, H Body fat mass and waist circumference increase postprandial lipemia in obese premenopausal women.
INT J OBESITY. 2004; 28 Suppl 3: S54-S54.-13th European Congress on Obesity; MAY 26-29, 2004; Prague, CZECH REPUBLIC.
Web of Science PubMed

 

** Mellitzer, K; Keinrath, P; Toplak, H Endothelial function following an oral fat load in obese premenopausal women.
INT J OBESITY. 2004; 28 Suppl 4(S1):S22-S22.-13th European Congress on Obesity; MAY 26-29, 2004; Prague, CZECH REPUBLIC.
Web of Science PubMed

 

** Toplak, H; Vercruysse, F; Sun, X; Fitchet, M Ramate as add-on to metformin (MET) in obese subjects with type 2 diabetes (T2DM)
INT J OBESITY 2004 28: S159-S159.
Web of Science

 

2003

Abstract (Zeitschrift)

** Hoegenauer, C; Hammer, HF; Mellitzer, K; Renner, W; Toplak, H Evaluation of a new genetic test compared to lactose hydrogen breath test for the diagnosis of acquired primary lactase deficiency
GASTROENTEROLOGY. 2003; 124(4): A64-A64. Doi: 10.1016/S0016-5085(03)80315-3
Web of Science FullText FullText_MUG

 

2001

Originalarbeit (Zeitschrift)

** deCampo, A; Schallmoser, K; Schmidt, H; Toplak, H; Kostner, GM A novel splice-site mutation in intron 7 causes more severe hypercholesterolemia than a combined FH-FDB defect.
ATHEROSCLEROSIS 2001 157: 524-525. Doi: 10.1016%2FS0021-9150%2801%2900535-4 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Hauner, H; Petzinna, D; Sommerauer, B; Toplak, H Effect of acarbose on weight maintenance after dietary weight loss in obese subjects.
Diabetes Obes Metab. 2001; 3(6):423-427 Doi: 10.1046%2Fj.1463-1326.2001.00156.x
Web of Science PubMed FullText FullText_MUG

 

Übersichtsarbeit

** Sinzinger, H; Hoppichler, F; Kritz, H; Laimer, H; Schmid, P; Silberbauer, K; Toplak, H; Osterreichische Arbeitsgemeinschaft für morphologische und funktionelle Atheroskleroseforschung HDL-2000: A consensus. HDL--a neglected lipoprotein
Wien Klin Wochenschr. 2001; 113(5-6):212-214
PubMed

 

Abstract (Zeitschrift)

** Toplak, H; Sharma, AM; Van Gaal, L Rapid weight loss with orlistat plus diet after 12 weeks of treatment
OBES RES 2001 9: 188S-188S.
Web of Science

 

2000

Originalarbeit (Zeitschrift)

** Renner, W; Köppel, H; Brodmann, M; Pabst, E; Schallmoser, K; Toplak, H; Wascher, TC; Pilger, E Factor II G20210A and factor V G1691A gene mutations and peripheral arterial occlusive disease.
THROMB HAEMOST. 2000; 83: 20-22. Doi: 10.1055/s-0037-1613750
Web of Science PubMed FullText FullText_MUG

 

** Renner, W; Köppel, H; Hoffmann, C; Schallmoser, K; Stanger, O; Toplak, H; Wascher, TC; Pilger, E Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
THROMB RES 2000 99: 35-39. Doi: 10.1016%2FS0049-3848%2http://dx.doi.org/10.1016%2FS0049-3848%2800%2900219-X
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Renner, W; Schallmoser, K; Gallippi, P; Krauss, C; Toplak, H; Wascher, TC; Pilger, E C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease.
ATHEROSCLEROSIS. 2000; 152: 175-179. Doi: 10.1016/S0021-9150(99)00448-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** Winklhofer-Roob, BM; Jerlich, A; de Campo, A; Roob, JM; Schaur, RJ; Toplak, H; Paulweber, B LDL susceptibility to copper- and hypochlorite-mediated oxidation in familial defective apolipoprotein B-100 (FDB).
FASEB J 2000 14: A521-A521.
Web of Science

 

1999

Originalarbeit (Zeitschrift)

** de Campo, A; Toplak, H; Wascher, TC; Schallmoser, K; Friehs, A; Schmidt, H; Kostner, GM Evaluation of a newly discovered LDL receptor mutation (exon 10, GAC>AAC, D271N, FH Graz-1) in familial hypercholesterolemia-- a familystudy
ACTA MED AUST 1999 26: 20-25.
Web of Science PubMed Google Scholar

 

** Toplak, H; Schallmoser, K; DeCampo, A Statins--attaining goal values--with reference to recent studies
Wien Med Wochenschr. 1999; 149(5-6): 144-145.
PubMed

 

** Wallner, S; Watzinger, N; Lindschinger, M; Smolle, KH; Toplak, H; Eber, B; Dittrich, P; Elmadfa, I; Klein, W; Krejs, GJ; Wascher, TC Effects of intensified lifestyle modification on the need for further revascularization after coronary angioplasty.
Eur J Clin Invest. 1999; 29(5):372-379 Doi: 10.1046/j.1365-2362.1999.00456.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1998

Originalarbeit (Zeitschrift)

** Toplak, H Effect of fat distribution on risk
Acta Med Austriaca. 1998; 25(4-5):131-132
Web of Science PubMed

 

** Toplak, H; Marhardt, K Reduction of obesity and improvement in metabolic parameters by inhibition of intestinal lipases: current results with orlistat
Acta Med Austriaca. 1998; 25(4-5):142-145
Web of Science PubMed

 

** Van Gaal, LF; Broom, JI; Enzi, G; Toplak, H Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study. Orlistat Dose-Ranging Study Group.
Eur J Clin Pharmacol. 1998; 54(2):125-132 Doi: 10.1007%2Fs002280050433
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Bammer, R; Stollberger, R; Bahadori, B; Wallner, S; Toplak, H Forearm composition contributes to differences in reactive hyperaemia between healthy men and women.
Eur J Clin Invest. 1998; 28(3):243-248 Doi: 10.1046%2Fj.1365-2362.1998.00270.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1997

Originalarbeit (Zeitschrift)

** Bahadori, B; Wallner, S; Schneider, H; Wascher, TC; Toplak, H Effect of chromium yeast and chromium picolinate on body composition of obese, non-diabetic patients during and after a formula diet
ACTA MED AUST 1997 24: 185-187.
Web of Science PubMed

 

** Wascher, TC; Graier, WF; Dittrich, P; Hussain, MA; Bahadori, B; Wallner, S; Toplak, H Effects of low-dose L-arginine on insulin-mediated vasodilatation and insulin sensitivity.
Eur J Clin Invest. 1997; 27(8):690-695 Doi: 10.1046%2Fj.1365-2362.1997.1730718.x
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Toplak, H; Bahadori, B; Wascher, TC CAPRIE trial.
Lancet. 1997; 349(9048):354; author reply 356-354; author reply 356 Doi: 10.1016/S0140-6736(05)62849-8
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Bahadori, B; Habersack-Wallner, S; Toplak, H Oral L-arginine supplementation in chronic heart failure.
Circulation. 1997; 95(6):1674-1675 [OPEN ACCESS]
Web of Science PubMed FullText Google Scholar

 

Abstract (Zeitschrift)

** Wallner, S; Watzinger, N; Lindschinger, M; Wascher, TC; Toplak, H; Smolle, KH; Elmadfa, I; Eber, B; Klein, W; Krejs, GJ Effects of intensified lifestyle modification on clinical restenosis after coronary angioplasty
ATHEROSCLEROSIS 1997 134: 268-268. Doi: 10.1016/S0021-9150(97)89410-5
Web of Science FullText FullText_MUG

 

** Wascher, TC; HabersackWallner, S; Bahadori, B; Roden, M; Novotny, P; Toplak, H Effects of melatonin supplementation on plasma leptin levels.
DIABETOLOGIA 1997 40: 1064-1064.
Web of Science

 

** Wascher, TC; Stollberger, R; Pammer, R; Wallner, S; Toplak, H Forearm composition determines peak reactive hyperemia and flow debt repayment in healthy subjects
ATHEROSCLEROSIS 1997 134: 95-95. Doi: 10.1016/S0021-9150(97)88548-6
Web of Science FullText FullText_MUG

 

1996

Originalarbeit (Zeitschrift)

** Bahadori, B; Neuer, E; Schumacher, M; Fruhwald, F; Eber, B; Klein, W; Toplak, H; Wascher, TC Prevalence of coronary artery disease in obese versus lean men with angina pectoris and positive exercise stress test.
Am J Cardiol. 1996; 77(11):1000-1001 Doi: 10.1016%2FS0002-9149%2896%2900038-0
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Haller, EM; Lauermann, T; Weber, K; Bahadori, B; Reisinger, EC; Tilz, GP; Wascher, TC Increased prevalence of IgA-Chlamydia antibodies in NIDDM patients.
Diabetes Res Clin Pract. 1996; 32(1-2):97-101 Doi: 10.1016/0168-8227(96)01216-8
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wascher, TC; Bachernegg, M; Kickenweiz, A; Stark, G; Stark, U; Toplak, H; Graier, WF Involvement of the L-arginine-nitric oxide pathway in hyperglycaemia-induced coronary artery dysfunction of isolated guinea pig hearts.
Eur J Clin Invest. 1996; 26(8):707-712 Doi: 10.1111/j.1365-2362.1996.tb02157.x
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** HabersackWallner, S; Kreuz, E; Graier, WF; Bahadori, B; Toplak, H; Wascher, TC Superoxide scavenging effects of free aminoacids
DIABETOLOGIA 1996 39: 855-855.
Web of Science

 

** Wascher, TC; Bahadori, B; Toplak, H Effects of L-arginine on insulin sensitivity and insulin mediated vasodilation in NIDDM.
DIABETES. 1996; 45: 571-571.
Web of Science

 

** Wascher, TC; Graier, WF; Bahadori, B; Toplak, H Effects of L-arginine on insulin-mediated vasodilation and insulin sensitivity in NIDDM and obesity.
DIABETOLOGIA 1996 39: 575-575.
Web of Science

 

1995

Originalarbeit (Zeitschrift)

** Geyer, G; Haidinger, G; Francesconi, M; Langmayr, N; Prager, R; Schoberberger, R; Toplak, H; von Kalckreuth, G; Kunze, M Effect of dexfenfluramine on eating behavior and body weight of obese patients: results of a field study of Isomeride in Austrian general practice
Acta Med Austriaca. 1995; 22(5):95-101
Web of Science PubMed

 

** Pokan, R; Schwaberger, G; Hofmann, P; Eber, B; Toplak, H; Gasser, R; Fruhwald, FM; Pessenhofer, H; Klein, W Effects of treadmill exercise protocol with constant and ascending grade on levelling-off O2 uptake and VO2 max.
INT J SPORT MED 1995 16: 238-242. Doi: 10.1055/s-2007-972998
Web of Science PubMed FullText FullText_MUG

 

** Sedlmayr, P; Plecko, B; Paschke, E; Zenz, W; Ramschak, H; Toplak, H; Wascher, TC; Wilders-Truschnig, M; Stöckler, S Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.
J Inherit Metab Dis. 1995; 18(1):101-102 Doi: 10.1007/BF00711394
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Wascher, TC; Weber, K; Lauermann, T; Reisinger, EC; Bahadori, B; Tilz, GP; Haller, EM Increased prevalence of serum IgA Chlamydia antibodies in obesity].
Acta Med Austriaca. 1995; 22(1-2):23-24
Web of Science PubMed

 

** Wascher, TC; Bachernegg, M; Kickenweiz, E; Stark, G; Stark, U; Toplak, H; Graier, WF; Krejs, GJ Elevation of D-glucose impairs coronary artery autoregulation after slight reduction of coronary flow.
Eur J Clin Invest. 1995; 25(8):590-594 Doi: 10.1111/j.1365-2362.1995.tb01750.x
Web of Science PubMed FullText FullText_MUG

 

Kurzbericht/Letter

** Toplak, H; Graier, W; Dittrich, P; Wiesmann, UN; Wascher, TC Insulin resistance and membrane abnormalities.
LANCET . 1995; 345(8955): 995; author reply 995-995; author reply 996. Doi: 10.1016/S0140-6736(95)90746-7
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** WASCHER, TC; GRAIER, WF; BAHADORI, B; TOPLAK, H L-ARGININE IMPROVES INSULIN-RESISTANCE IN OBESE PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
DIABETOLOGIA 1995 38: A158-A158.
Web of Science

 

1994

Originalarbeit (Zeitschrift)

** Fruhwald, FM; Eber, B; Toplak, H; Fruhwald, SM; Dusleag, J; Pätzold, D; Harnoncourt, K; Klein, W 10-year-follow-up of patients with silent Cohn type 1 myocardial ischemia
Acta Med Austriaca. 1994; 21(3):89-93
Web of Science PubMed

 

** Nuoffer, JM; Pfammatter, JP; Spahr, A; Toplak, H; Wanders, RJ; Schutgens, RB; Wiesmann, UN Chondrodysplasia punctata with a mild clinical course.
J Inherit Metab Dis. 1994; 17(1):60-66 Doi: 10.1007/BF00735395 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

** Wascher, TC; Toplak, H; Krejs, GJ; Simecek, S; Kukovetz, WR; Graier, WF Intracellular mechanisms involved in D-glucose-mediated amplification of agonist-induced Ca2+ response and EDRF formation in vascular endothelial cells.
Diabetes. 1994; 43(8):984-991 Doi: 10.2337/diabetes.43.8.984
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Zweiker, R; Eber, B; Schumacher, M; Toplak, H; Klein, W Non-dipping related to cardiovascular events in essential hypertensive patients.
ACTA MED AUST. 1994; 21(3): 86-89.
Web of Science PubMed

 

Kurzbericht/Letter

** Wascher, TC; Dittrich, P; Toplak, H; Graier, WG Endothelial dysfunction in hypertension.
Lancet. 1994; 344(8921):549-550 Doi: 10.1016/S0140-6736(94)91946-1
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wascher, TC; Graier, WF; Bahadori, B; Toplak, H Time course of endothelial dysfunction in diabetes mellitus.
Circulation. 1994; 90(2):1109-1110 Doi: 10.1161/01.CIR.90.2.1109 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Wascher, TC; Toplak, H Endothelial dysfunction and diabetic angiopathy.
DIABETOLOGIA . 1994; 37(11): 1167-1168. Doi: 10.1007/BF00418383 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** TOPLAK, H; WASCHER, TC; GRUBENTHAL, I; DITTRICH, P; GRAIER, WF; KREJS, GJ AMINOGUANIDINE REESTABLISHES VASCULAR ENDOTHELIAL-CELL REPARATIVE POTENCY UNDER HYPERGLYCEMIC CONDITIONS
DIABETOLOGIA. 1994; 37: A54-A54.
Web of Science

 

** WASCHER, TC; BACHERNEGG, M; STARK, G; TOPLAK, H; DITTRICH, P; GRAIER, WF; KREJS, GJ VASODILATION INDUCED BY SLIGHT HYPOXIA UNDER HYPERGLYCEMIC CONDITIONS DEPENDS ON THE AVAILABILITY OF L-ARGININE
DIABETOLOGIA. 1994; 37: A23-A23.
Web of Science

 

Kurzbericht/Note

** Toplak, H; Sagmeister, E; Wascher, TC Cardiovascular risk factors in obesity. The effect of weight reduction on platelet size in overweight patients.
Int J Obes Relat Metab Disord. 1994; 18(5):355-356
Web of Science PubMed Google Scholar

 

** Toplak, H; Wascher, TC Influence of weight reduction on platelet volume: different effects of a hypocaloric diet and a very low calorie diet.
Eur J Clin Invest. 1994; 24(11):778-780 Doi: 10.1111/j.1365-2362.1994.tb01076.x
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Wascher, TC; Pleschko, B; Ramschak, H; Sedlmayr, P; Wilders-Truschnigg, M; Stöckler, S Reduced stimulability of platelet surface adhesion molecules under treatment with Lorenzo's oil.
J Inherit Metab Dis. 1994; 17(5):628-629 Doi: 10.1007/BF00711605
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1993

Originalarbeit (Zeitschrift)

** Graier, WF; Wascher, TC; Lackner, L; Toplak, H; Krejs, GJ; Kukovetz, WR Exposure to elevated D-glucose concentrations modulates vascular endothelial cell vasodilatory response.
Diabetes. 1993; 42(10):1497-1505 Doi: 10.2337/diabetes.42.10.1497
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Honegger, UE; Zuehlke, RD; Scuntaro, I; Schaefer, MH; Toplak, H; Wiesmann, UN Cellular accumulation of amiodarone and desethylamiodarone in cultured human cells. Consequences of drug accumulation on cellular lipid metabolism and plasma membrane properties of chronically exposed cells.
Biochem Pharmacol. 1993; 45(2):349-356 Doi: 10.1016/0006-2952(93)90070-D
Web of Science PubMed FullText FullText_MUG

 

** Schumacher, M; Eber, B; Schallmoser, K; Toplak, H; Zweiker, R; Lindschinger, M; Sommer, K; Klein, W Eating behavior of patients with metabolic diseases and metabolically healthy probands in Austria. Results of a questionnaire survey at the Graz Autumn Fair 1991
Wien Med Wochenschr. 1993; 143(12): 329-332.
PubMed

 

** Toplak, H; Haller, EM; Lauermann, T; Weber, K; Tilz, GP; Wascher, TC Serum concentration of soluble intercellular adhesion molecule 1 in chlamydial infection in diabetes mellitus type II.
Clin Investig. 1993; 71(10):806-806 Doi: 10.1007/BF00190323
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** PIEBER, TR; SEMLITSCH, B; SCHNEDL, WJ; BRUNNER, GA; TOPLAK, H; SAGMEISTER, EM; SCHATTENBERG, S; KREJS, GJ EVALUATION OF A 5-DAY OUTPATIENT TEACHING PROGRAM FOR INTENSIFIED INSULIN THERAPY - A 3 YEAR FOLLOW-UP
DIABETOLOGIA. 1993; 36: A158-A158.
Web of Science

 

** WASCHER, TC; LACKNER, L; TOPLAK, H; GRAIER, WF MECHANISMS OF GLUCOSE-MEDIATED INCREASES IN THE FORMATION OF ENDOTHELIUM-DERIVED-RELAXING-FACTOR
DIABETOLOGIA. 1993; 36: A12-A12.
Web of Science

 

1992

Originalarbeit (Zeitschrift)

** Baciulis, V; Luthy, C; Hofer, G; Toplak, H; Wiesmann, UN; Oetliker, OH Specific and non specific stimulation of prostaglandin release by human skin fibroblasts in culture.--Are changes of membrane fluidity involved?
Prostaglandins. 1992; 43(3):293-304 Doi: 10.1016/0090-6980(92)90097-D
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Eber, B; Schumacher, M; Auergrumbach, P; Toplak, H; Klein, W Increased IgM-anticardiolipin antibodies in patients with restenosis after percutaneous transluminal coronary angioplasty.
Am J Cardiol. 1992; 69(16):1255-1258 Doi: 10.1016/0002-9149(92)91216-Q
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schumacher, M; Eber, B; Tiran, A; Toplak, H; Luha, O; Gasser, R; Klein, W Fibrinogen values in patients with and without restenosis following percutaneous transluminal coronary angiography.
Cardiology. 1992; 80(5-6):345-348 Doi: 10.1159/000175024
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Sojcic, Z; Toplak, H; Zuehlke, R; Honegger, UE; Bühlmann, R; Wiesmann, UN Cultured human skin fibroblasts modify their plasma membrane lipid composition and fluidity according to growth temperature suggesting homeoviscous adaptation at hypothermic (30 degrees C) but not at hyperthermic (40 degrees C) temperatures.
Biochim Biophys Acta. 1992; 1104(1):31-37 Doi: 10.1016/0005-2736(92)90128-9
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Schumacher, M; Eber, B; Luha, O; Klein, W; Krejs, GJ Microalbuminuria is no risk factor for restenosis following percutaneous transluminal coronary angioplasty.
Clin Investig. 1992; 70(11):1010-1012 Doi: 10.1007/BF00180310
Web of Science PubMed FullText FullText_MUG

 

Abstract (Zeitschrift)

** TOPLAK, H; HALLER, EM; LAUERMANN, T; TILZ, GP; WEBER, K; SCHNEDL, W; WASCHER, T; HAAS, A; SCHMUT, O INCREASED RISK FOR ACTIVE CHLAMYDIA INFECTION IN TYPE-II DIABETES-MELLITUS
DIABETOLOGIA. 1992; 35: A142-A142.
Web of Science

 

** WEBER, K; STIEGLER, C; TOPLAK, H; SCHNEDL, W; LEB, G; KREJS, GJ PREDICTING RISK OF OSTEOPOROSIS SUBSEQUENT TO REDUCED BONE-FORMATION IN FEMALE JUVENILE DIABETICS BY MEASUREMENT OF PEAK BONE MASS
DIABETOLOGIA. 1992; 35: A192-A192.
Web of Science

 

Kommentar

** SCHUMACHER, M; EBER, B; TOPLAK, H; KLEIN, W Routine lipid profile in patients with and without restenosis after percutaneous transluminal coronary angioplasty.
Am J Cardiol. 1992; 70(20):1640-1640 Doi: 10.1016/0002-9149(92)90485-H
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Schumacher, M; Tiran, A; Eber, B; Toplak, H; Wilders-Truschnig, M; Klein, W Lipoprotein (a) is not a risk factor for restenosis after percutaneous transluminal coronary angioplasty.
Am J Cardiol. 1992; 69(5):572-572 Doi: 10.1016/0002-9149(92)91011-R
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1991

Übersichtsarbeit

** Fruhwald, FM; Eber, B; Rotman, B; Toplak, H; Klein, W Silent myocardial ischemia. Current concepts of prognosis and therapy
ACTA MED AUST. 1991; 18(4): 90-92.
Web of Science PubMed

 

** Fruhwald, FM; Eber, B; Rotman, B; Toplak, H; Klein, W; Lind, P Silent myocardial ischemia. Current concepts of pathophysiology and diagnosis
ACTA MED AUST. 1991; 18(4): 85-89.
Web of Science PubMed

 

1990

Originalarbeit (Zeitschrift)

** Stradner, F; Pieber, T; Toplak, H; Schreiber, U; Pfeiffer, KP Insulin-sulfonylurea combination therapy in secondary therapy failure with sulfonylurea compounds. Randomized study between evening and morning intermediary insulin administration using the Novo Pen semi-automatic insulin injector
SCHWEIZ MED WOCHENSCHR. 1990; 120: 989-994.
Web of Science PubMed Google Scholar

 

** Toplak, H; Batchiulis, V; Hermetter, A; Hunziker, T; Honegger, UE; Wiesmann, UN Effects of culture and incubation conditions on membrane fluidity in monolayers of cultured cells measured as fluorescence anisotropy using trimethylammoniumdiphenylhexatriene (TMA-DPH).
Biochim Biophys Acta. 1990; 1028(1):67-72 Doi: 10.1016/0005-2736(90)90266-Q
Web of Science PubMed FullText FullText_MUG Google Scholar

 

** Toplak, H; Zuehlke, R; Loidl, S; Hermetter, A; Honegger, UE; Wiesmann, UN Single and multiple desipramine exposures of cultured cells. Changes in cellular anisotropy and in lipid composition of whole cells and of plasma membranes.
Biochem Pharmacol. 1990; 39(9):1437-1443 Doi: 10.1016/0006-2952(90)90425-K
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Abstract (Zeitschrift)

** BATCHIULIS, V; TOPLAK, H; WIESMANN, U EFFECT OF CYCLOSPORINE-A (CSA) AND VERAPAMIL ON MEMBRANE FLUIDITY OF CULTURED HUMAN SKIN FIBROBLASTS (HSF)
PEDIAT RES. 1990; 28(3): 285-285. Doi: 10.1203/00006450-199009000-00075
Web of Science FullText FullText_MUG

 

1988

Abstract (Zeitschrift)

** BATCHIULIS, V; TOPLAK, H; LUTHY, C; WIESMANN, U; OETLIKER, O RESPONSE OF PROSTAGLANDIN (PG) SYNTHESIS AND MEMBRANE FLUIDITY TO CHANGES OF OSMOLALITY IN CULTURED HUMAN-SKIN FIBROBLASTS (HSF)
PEDIAT RES. 1988; 24(2): 270-270. Doi: 10.1203/00006450-198808000-00087
Web of Science FullText FullText_MUG

 

** TOPLAK, H; HERMETTER, A; WIESMANN, UN INSITU FLUORESCENCE ANISOTROPY MEASUREMENTS IN CULTURED-CELLS BY A COVERSLIP TECHNIQUE USING 1-(4-TRIMETHYLAMMONIUMPHENYL)-6-PHENYL-1, 3, 5-HEXATRIENE (TMA-DPH)
PEDIAT RES. 1988; 24(2): 270-270. Doi: 10.1203/00006450-198808000-00084
Web of Science FullText FullText_MUG

 

1987

Abstract (Zeitschrift)

** TOPLAK, H; HERMETTER, A; HONEGGER, U; WIESMANN, U MEMBRANE FLUIDITY - A NEW BIOPHYSICAL METHOD FOR STUDIES OF DRUG EFFECTS IN HUMAN-FIBROBLASTS
PEDIAT RES. 1987; 22(2): 217-217. Doi: 10.1203/00006450-198708000-00023
Web of Science FullText FullText_MUG

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum